IRIDEX Corp
IRIX1.310USD
+0.030+2.34%
Market hours （ET）Quotes delayed by 15 min
21.99MMarket Cap
LossP/E TTM
More Details of IRIDEX Corp Company
IRIDEX Corporation is an ophthalmic medical technology company. It develops and commercializes products and procedures used to treat sight-threatening eye conditions, including glaucoma and retinal diseases. Its MicroPulse Technology and Endpoint Management Technology are used for the treatment of glaucoma and retina disorders. Its laser consoles product consists of Glaucoma, Medical Retina and Surgical Retina. Its glaucoma console line is the Cyclo G6 laser system with MicroPulse technology. Its surgical-retina product line includes its OcuLight TX and OcuLight SLx laser photocoagulation systems. Its medical-retina product line includes its portable IQ 532 and IQ 577 laser systems. Its laser probes products include Glaucoma and Surgical Retina. Probes used in its glaucoma product line include its patented single-use delivery devices-MicroPulse P3, G-Probe, and G-Probe Illuminate. Probes used in its surgical retina product line include its family of single-use EndoProbe handpieces.
Company Info
Ticker SymbolIRIX
Company nameIRIDEX Corp
IPO dateFeb 16, 1996
CEOMr. Patrick Mercer
Number of employees93
Security typeOrdinary Share
Fiscal year-endFeb 16
Address1212 Terra Bella Ave
CityMOUNTAIN VIEW
Stock exchangeNASDAQ Capital Market Consolidated
CountryUnited States of America
Postal code94043
Phone16509404700
Websitehttps://www.iridex.com/
Ticker SymbolIRIX
IPO dateFeb 16, 1996
CEOMr. Patrick Mercer
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. William M. (Will) Moore, Jr.
Mr. William M. (Will) Moore, Jr.
Independent Director
Independent Director
287.98K
+21.01%
Mr. Patrick Mercer
Mr. Patrick Mercer
President, Chief Executive Officer, Chief Operating Officer, Director
President, Chief Executive Officer, Chief Operating Officer, Director
123.99K
+31.05%
Ms. Beverly A. Huss
Ms. Beverly A. Huss
Independent Director
Independent Director
92.64K
+237.21%
Mr. Bassem Bouhabib
Mr. Bassem Bouhabib
Vice President - International Sales
Vice President - International Sales
89.99K
--
Mr. Romeo R. Dizon
Mr. Romeo R. Dizon
Chief Financial Officer
Chief Financial Officer
44.34K
+132.62%
Mr. Scott A. Shuda, J.D.
Mr. Scott A. Shuda, J.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Yu Hao (Nick) Chen
Mr. Yu Hao (Nick) Chen
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. William M. (Will) Moore, Jr.
Mr. William M. (Will) Moore, Jr.
Independent Director
Independent Director
287.98K
+21.01%
Mr. Patrick Mercer
Mr. Patrick Mercer
President, Chief Executive Officer, Chief Operating Officer, Director
President, Chief Executive Officer, Chief Operating Officer, Director
123.99K
+31.05%
Ms. Beverly A. Huss
Ms. Beverly A. Huss
Independent Director
Independent Director
92.64K
+237.21%
Mr. Bassem Bouhabib
Mr. Bassem Bouhabib
Vice President - International Sales
Vice President - International Sales
89.99K
--
Mr. Romeo R. Dizon
Mr. Romeo R. Dizon
Chief Financial Officer
Chief Financial Officer
44.34K
+132.62%
Mr. Scott A. Shuda, J.D.
Mr. Scott A. Shuda, J.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Revenue Breakdown
Currency: USDUpdated: Sun, Jul 6
Currency: USDUpdated: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
By BusinessUSD
Name
Revenue
Proportion
Retina
6.64M
55.86%
G6
3.18M
26.74%
Other
2.07M
17.40%
By RegionUSD
Name
Revenue
Proportion
United States
5.28M
44.41%
Asia/Pacific Rim
3.36M
28.24%
Europe & Middle East & Africa
2.86M
24.05%
Rest of the Americas
392.00K
3.30%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Retina
6.64M
55.86%
G6
3.18M
26.74%
Other
2.07M
17.40%
Shareholding Stats
Updated: Fri, May 16
Updated: Fri, May 16
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Topcon Corp
9.64%
Stanley Manne Trust
6.39%
Paragon JV Partners, LLC
5.96%
The Vanguard Group, Inc.
3.54%
AMH Equity, Ltd.
3.09%
Other
71.39%
Shareholders
Shareholders
Proportion
Topcon Corp
9.64%
Stanley Manne Trust
6.39%
Paragon JV Partners, LLC
5.96%
The Vanguard Group, Inc.
3.54%
AMH Equity, Ltd.
3.09%
Other
71.39%
Shareholder Types
Shareholders
Proportion
Corporation
18.13%
Hedge Fund
11.78%
Individual Investor
10.04%
Investment Advisor
5.28%
Investment Advisor/Hedge Fund
1.49%
Venture Capital
0.06%
Other
53.21%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
61
7.86M
46.79%
+643.51K
2025Q1
57
6.59M
39.89%
-547.85K
2024Q4
56
6.67M
40.12%
-576.91K
2024Q3
56
6.58M
39.55%
-791.78K
2024Q2
63
7.41M
45.29%
-103.92K
2024Q1
64
7.34M
45.55%
+258.49K
2023Q4
68
7.28M
45.21%
-25.53K
2023Q3
68
7.58M
47.03%
+345.93K
2023Q2
71
7.91M
49.44%
+523.96K
2023Q1
78
8.45M
52.97%
-216.41K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Topcon Corp
1.62M
9.64%
+6.00K
+0.37%
Apr 01, 2025
Stanley Manne Trust
1.07M
6.39%
--
--
Apr 01, 2025
Paragon JV Partners, LLC
1.00M
5.96%
--
--
Mar 31, 2025
The Vanguard Group, Inc.
594.79K
3.54%
+33.69K
+6.00%
Mar 31, 2025
AMH Equity, Ltd.
518.54K
3.09%
+17.42K
+3.48%
Mar 31, 2025
Roland (Brent Alexander)
461.71K
2.75%
+461.71K
--
Apr 01, 2025
Renaissance Technologies LLC
379.16K
2.26%
-2.00K
-0.52%
Mar 31, 2025
Moore (William M)
287.98K
1.72%
+50.00K
+21.01%
Jun 13, 2025
Roland Family Support Trust
223.69K
1.33%
+223.69K
--
Apr 01, 2025
Roland (Glenn Cuthbert)
181.60K
1.08%
+181.60K
--
Apr 01, 2025
View more
Related ETFs
Updated: Sat, Aug 2
Updated: Sat, Aug 2
Name
Proportion
iShares Micro-Cap ETF
0%
iShares Micro-Cap ETF
Proportion0%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
